Showing results (51-60 of 107) with videos related to

Sort By:
Pageof 11
Blood|July 21, 2007
CCR1/CCL5 (RANTES) receptor-ligand interactions modulate allogeneic T-cell responses and graft-versus-host disease following stem-cell transplantationSung W Choi, Gerhard C Hildebrandt, Krystyna M Olkiewicz, et al.
Blood|November 15, 2003
A critical role for CCR2/MCP-1 interactions in the development of idiopathic pneumonia syndrome after allogeneic bone marrow transplantationGerhard C Hildebrandt, Ulrich A Duffner, Krystyna M Olkiewicz, et al.
Blood Advances|April 18, 2025
Delayed T cell recovery after hematopoietic cell transplantation is associated with decreased overall survival in adultsMiguel-Angel Perales, Marcie Riches, Naya He, et al.
Transplantation and Cellular Therapy|June 1, 2022
Natural Killer Cell Alloreactivity Predicted By Killer Cell Immunoglobulin-Like Receptor Ligand Mismatch Does Not Impact Engraftment in Umbilical Cord Blood and Haploidentical Stem Cell TransplantationFolashade Otegbeye, Marcelo A Fernandez Vina, Tao Wang, et al.
Blood|April 27, 2018
Novel role of prostate apoptosis response-4 tumor suppressor in B-cell chronic lymphocytic leukemiaMary K McKenna, Sunil K Noothi, Sara S Alhakeem, et al.
The Lancet. Oncology|July 15, 2022
Lisocabtagene maraleucel as second-line therapy in adults with relapsed or refractory large B-cell lymphoma who were not intended for haematopoietic stem cell transplantation (PILOT): an open-label, phase 2 studyAlison Sehgal, Daanish Hoda, Peter A Riedell, et al.
Blood Advances|April 30, 2025
Lisocabtagene maraleucel for R/R LBCL in patients not intended for HSCT: final results of the phase 2 PILOT studyAlison Sehgal, Daanish Hoda, Peter A Riedell, et al.
Transplantation and Cellular Therapy|October 12, 2021
Chronic Graft-versus-Host Disease, Nonrelapse Mortality, and Disease Relapse in Older versus Younger Adults Undergoing Matched Allogeneic Peripheral Blood Hematopoietic Cell Transplantation: A Center for International Blood and Marrow Transplant Research AnalysisVijaya Raj Bhatt, Tao Wang, Karen Chen, et al.
Cancer|April 6, 2023
Impact of bortezomib-based versus lenalidomide maintenance therapy on outcomes of patients with high-risk multiple myelomaNaresh Bumma, Binod Dhakal, Raphael Fraser, et al.
Transplantation and Cellular Therapy|November 28, 2022
Adapting the HCT-CI Definitions for Children, Adolescents, and Young Adults with Hematologic Malignancies Undergoing Allogeneic Hematopoietic Cell TransplantationBrian D Friend, Larisa Broglie, Brent R Logan, et al.
Pageof 11